Teishima, J. (2024) “Therapeutic outcome of combination therapy using immune-checkpoint inhibitors and tyrosine kinase inhibitors for metastatic non-clear-cell renal cell carcinoma ”, Canadian Urological Association Journal, 18(5), pp. E162–6. doi: 10.5489/cuaj.8548.